Possibility of a patch system as a new oral delivery system

被引:26
作者
Eaimtrakarn, S [1 ]
Prasad, YVR [1 ]
Puthli, SP [1 ]
Yoshikawa, Y [1 ]
Shibata, N [1 ]
Takada, K [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Pharmacokinet, Yamashina Ku, Kyoto 6078414, Japan
基金
日本学术振兴会;
关键词
patch preparation; oral delivery; absorption; mean residence time; fluorescein; fluorescein isothiocyanate-dextran; rats;
D O I
10.1016/S0378-5173(02)00534-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new oral patch system has been designed to increase the residence time of model drugs within the gastrointestinal tract. The system consisted of three layers (1) water-insoluble backing layer (2) drug-carrying adhesive layer composed of a model drug, fluorescein (FL) or fluorescein isothiocyanate-dextran (FD), and gel-forming polymer and (3) pH-sensitive enteric polymer. These three layers system was prepared as 3.0 mm diameter patches. As references, tablet containing FL or FD was prepared. In vitro dissolution studies showed that the mean dissolution time (MDT) of model drugs from patch preparation was 0.739+/-0.021 h for FL and 0.407+/-0.021 h for FD, which were longer than from tablet, 0.327+/-0.008 h for FL and 0.270+/-0.019 h for FD. The two test preparations were orally administered to beagle dogs in a crossover manner at a FL dose of 30 mg/dog and the measured plasma FL concentrations were used for pharmacokinetic analysis. With FL patch preparation, area under the plasma drug concentration vs. time curve (AUC) was 2.12+/-0.24 mug h/ml and mean residence time (MRT) was 4.60+/-0.18 h, which were greater than those of tablet, AUC was 1.52+/-0.16 mug h/ml and MRT was 3.18+/-0.09 h, respectively. Oral patch preparation also increased both AUC and MRT of FD, a model macromolecular drug, which was formulated into both patches and tablets and administered to dogs (30 mg/dog). The AUC and MRT of FD from the patch preparation were 1.11+/-0.13 mug h/ml and 5.58+/-0.55 h and from tablets were 0.53+/-0.08 mug h/ml and 4.09+/-0.29 h, respectively. These results suggest that oral patch preparation has a potential as a new oral delivery system to obtain a long residence time of drug in the gastrointestinal tract. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 27 条
[1]  
[Anonymous], [No title captured]
[2]  
CLAUDIO N, 2000, J CONTROL RELEASE, V68, P237
[3]   NANOCAPSULES AS CARRIERS FOR ORAL PEPTIDE DELIVERY [J].
DAMGE, C ;
MICHEL, C ;
APRAHAMIAN, M ;
COUVREUR, P ;
DEVISSAGUET, JP .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) :233-239
[4]   Retention and transit of intestinal mucoadhesive films in rat small intestine [J].
Eaimtrakarn, S ;
Itoh, Y ;
Kishimoto, J ;
Yoshikawa, Y ;
Shibata, N ;
Takada, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 224 (1-2) :61-67
[5]   Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein [J].
Eiamtrakarn, S ;
Itoh, Y ;
Kishimoto, J ;
Yoshikawa, Y ;
Shibata, N ;
Murakami, M ;
Takada, K .
BIOMATERIALS, 2002, 23 (01) :145-152
[6]  
HAYASHI T, 1999, J PHARM SCI TECHNOL, V59, P148
[7]   FORMULATIONS RELEASING THE DRUG PROXIMAL TO THE PYLORUS IN THE DOG [J].
HEINAMAKI, J ;
MARVOLA, M ;
HAPPONEN, I ;
WESTERMARCK, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :51-61
[8]   THE USE OF BIOADHESIVES IN TARGETED DELIVERY WITHIN THE GASTROINTESTINAL-TRACT [J].
HELLIWELL, M .
ADVANCED DRUG DELIVERY REVIEWS, 1993, 11 (03) :221-251
[9]  
Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO
[10]  
2-G